Glucose Intolerance: Definition, Tests, and How It Differs

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • Glucose intolerance is an umbrella term for impaired fasting glucose (IFG, 100 to 125 mg/dL) and impaired glucose tolerance (IGT, 2-hour OGTT 140 to 199 mg/dL).
  • Both conditions sit between normal glucose handling and frank diabetes; they are the two diagnostic criteria for prediabetes.
  • Diagnosis requires a fasting glucose, a 2-hour OGTT, an A1C, or some combination, with confirmation on a separate day.
  • Lifestyle changes (Diabetes Prevention Program-style) can reverse glucose intolerance and reduce progression to diabetes by about 58 percent over three years.

Glucose intolerance is a clinical umbrella term for blood sugar levels that are higher than normal but not yet in the diabetes range. It includes two specific conditions: impaired fasting glucose (IFG, fasting 100 to 125 mg/dL) and impaired glucose tolerance (IGT, 2-hour oral glucose tolerance test 140 to 199 mg/dL). Together they make up what most patients and clinicians today call prediabetes.

The Two Faces of Glucose Intolerance

Impaired Fasting Glucose (IFG)

IFG is diagnosed when your fasting plasma glucose, measured after an overnight fast of at least 8 hours, falls between 100 and 125 mg/dL. It reflects increased liver glucose output overnight and reduced first-phase insulin response.

Impaired Glucose Tolerance (IGT)

IGT is diagnosed via the oral glucose tolerance test (OGTT). After fasting, you drink a 75-gram glucose solution and have blood drawn 2 hours later. A value between 140 and 199 mg/dL signals IGT. It reflects reduced muscle glucose uptake after meals.

You can have IFG, IGT, both, or neither. About a quarter to a third of people with one have the other. People with both have a higher annual risk of progression to diabetes than those with one alone.

Glucose Intolerance vs Prediabetes vs Diabetes

Test Normal Glucose intolerance / Prediabetes Diabetes
Fasting plasma glucose Below 100 mg/dL 100 to 125 mg/dL (IFG) 126 mg/dL or higher
2-hour OGTT (75 g glucose) Below 140 mg/dL 140 to 199 mg/dL (IGT) 200 mg/dL or higher
Hemoglobin A1C Below 5.7 percent 5.7 to 6.4 percent 6.5 percent or higher
Random glucose with symptoms Below 200 mg/dL Not diagnostic 200 mg/dL or higher with symptoms

How the Oral Glucose Tolerance Test Works

The OGTT remains the most sensitive test for glucose intolerance because it captures the post-meal response, where problems often appear before fasting glucose creeps up. Steps:

  1. Eat a normal carbohydrate diet (at least 150 g/day) for 3 days before the test.
  2. Fast overnight for at least 8 hours; water is allowed.
  3. Have a baseline fasting blood draw.
  4. Drink the 75 g glucose solution within 5 minutes (it tastes like flat, very sweet soda).
  5. Stay in the lab for 2 hours; avoid eating, smoking, or significant activity.
  6. Have a second blood draw at 2 hours.

Some clinicians or pregnant patients use a 1-hour or 3-hour version, but the 2-hour 75 g protocol is the WHO and ADA standard for non-pregnant adults.

Why Glucose Intolerance Develops

Two physiological problems converge:

  • Insulin resistance in muscle, fat, and liver, often driven by excess intra-abdominal fat, sedentary lifestyle, and aging
  • Beta-cell dysfunction, where the pancreas no longer compensates with enough extra insulin to overcome the resistance

Risk factors include family history, age over 45, BMI over 25 (or over 23 in Asian populations), gestational diabetes history, polycystic ovary syndrome, hypertension, and certain ethnic backgrounds (African American, Hispanic, Native American, Asian American, Pacific Islander).

Why It Matters: The Risk of Progression

Without intervention, roughly 5 to 10 percent of people with prediabetes progress to type 2 diabetes each year. Over 10 years, the cumulative risk is substantial. Glucose intolerance also increases risk of cardiovascular disease, even before diabetes develops, because the same insulin resistance that drives high glucose also worsens lipids and blood pressure.

How to Reverse It

The landmark Diabetes Prevention Program (DPP), published in the New England Journal of Medicine in 2002, randomized over 3,000 adults with IGT to placebo, metformin, or an intensive lifestyle program. After 2.8 years:

  • Lifestyle group reduced diabetes incidence by 58 percent
  • Metformin group reduced incidence by 31 percent
  • Lifestyle benefit was strongest in adults over 60

The lifestyle protocol targeted 7 percent weight loss and 150 minutes of moderate exercise per week, paired with structured coaching. Long-term follow-up continues to show benefit. For specific food choices, see our diet and nutrition guide and the deeper analysis in Is Prediabetes Reversible?

What an Action Plan Looks Like

  1. Get a confirmed diagnosis with at least two abnormal tests, ideally an A1C plus a fasting or OGTT result.
  2. Aim for 5 to 7 percent body weight loss over 6 to 12 months if BMI is above 25.
  3. Move regularly: 150 minutes of moderate aerobic activity weekly, plus 2 days of resistance training.
  4. Cut refined carbs and sugary drinks; favor whole grains, legumes, vegetables, and lean proteins.
  5. Improve sleep to at least 7 hours and address sleep apnea if present.
  6. Discuss metformin with your clinician if BMI is over 35, you are under 60, you had gestational diabetes, or A1C is climbing despite lifestyle changes.
  7. Recheck A1C every 6 months until stable.

Bariatric and Pharmacological Options

For higher-risk individuals or those who do not respond to lifestyle alone, options include metformin, GLP-1 receptor agonists (such as semaglutide and tirzepatide, which have shown weight loss and glucose benefit), and bariatric surgery. The right choice depends on weight, comorbidities, cost, and patient preference.

The Bottom Line

Glucose intolerance is the diagnostic name for prediabetes, divided into impaired fasting glucose and impaired glucose tolerance based on the test used. It signals that your insulin response is starting to fall short of demand, but the trajectory is highly modifiable. Lose modest weight, move daily, eat fewer refined carbs, sleep better, and revisit your numbers in 6 months. Many people normalize their values and step back from the diabetes ledge.

Medical disclaimer: This article is for educational purposes only and is not medical advice. Always consult your physician or qualified healthcare provider about your individual situation.

Frequently Asked Questions

Is glucose intolerance the same as prediabetes?

Yes, in most clinical usage they are used interchangeably. Prediabetes is the broader patient-friendly term; glucose intolerance is the older clinical phrase that includes both impaired fasting glucose and impaired glucose tolerance. Both refer to blood sugar values higher than normal but not yet meeting diabetes criteria.

How is glucose intolerance diagnosed?

Diagnosis uses one of three tests. Fasting plasma glucose 100 to 125 mg/dL indicates impaired fasting glucose. A 2-hour value of 140 to 199 mg/dL on the 75 g oral glucose tolerance test indicates impaired glucose tolerance. A1C between 5.7 and 6.4 percent also qualifies. A confirmatory test on a separate day is recommended.

Can glucose intolerance be reversed?

Yes. The Diabetes Prevention Program showed that 7 percent body weight loss combined with 150 minutes of moderate weekly exercise cut progression to type 2 diabetes by 58 percent. Many participants returned to normal glucose values. Early intervention, when insulin sensitivity is still mostly intact, gives the best results.

Sources

  1. American Diabetes Association. Standards of Care in Diabetes 2024.
  2. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 2002.
  3. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia.